<code id='0EAAC5C13E'></code><style id='0EAAC5C13E'></style>
    • <acronym id='0EAAC5C13E'></acronym>
      <center id='0EAAC5C13E'><center id='0EAAC5C13E'><tfoot id='0EAAC5C13E'></tfoot></center><abbr id='0EAAC5C13E'><dir id='0EAAC5C13E'><tfoot id='0EAAC5C13E'></tfoot><noframes id='0EAAC5C13E'>

    • <optgroup id='0EAAC5C13E'><strike id='0EAAC5C13E'><sup id='0EAAC5C13E'></sup></strike><code id='0EAAC5C13E'></code></optgroup>
        1. <b id='0EAAC5C13E'><label id='0EAAC5C13E'><select id='0EAAC5C13E'><dt id='0EAAC5C13E'><span id='0EAAC5C13E'></span></dt></select></label></b><u id='0EAAC5C13E'></u>
          <i id='0EAAC5C13E'><strike id='0EAAC5C13E'><tt id='0EAAC5C13E'><pre id='0EAAC5C13E'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:34758
          Merck logo — policy coverage from STAT
          Mel Evans/AP

          Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

          The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

          advertisement

          Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Paying for Covid pills will soon shift to insurers
          Paying for Covid pills will soon shift to insurers

          PayingforCovidpills,includingPaxlovid,willshifttoinsurersstartingnextweek.JoeRaedle/GettyImagesWASHI

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Maker of FluMist seeks to allow at

          ApatientreceivestheFluMistvaccineduringaclinicinSilverSpring,Md.TIMSLOAN/AFP/GettyImagesPeopleeligib